Actelion acquires new formulation of hypertension drug from GeneraMedix
Actelion, a biopharmaceutical company, has entered into a definitive agreement to acquire an improved, thermostable formulation of epoprostenol sodium for the intravenous treatment of pulmonary arterial hypertension from GeneraMedix, a provider of injectable products.